VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
1-Year Return
23.01%
This Quarter Return
+12.86%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$158M
AUM Growth
-$7.14M
(-4.3%)
Cap. Flow
-$21.5M
Cap. Flow
% of AUM
-13.64%
Top 10 Holdings %
Top 10 Hldgs %
5.64%
Holding
474
New
40
Increased
153
Reduced
231
Closed
49
Top Buys
| 1 |
Expedia Group
EXPE
|
$932K |
| 2 |
Prologis
PLD
|
$773K |
| 3 |
Gartner
IT
|
$769K |
| 4 |
Quanta Services
PWR
|
$762K |
| 5 |
Trane Technologies
TT
|
$759K |
Top Sells
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$854K |
| 2 |
Arthur J. Gallagher & Co
AJG
|
$778K |
| 3 |
IDEX
IEX
|
$731K |
| 4 |
Tesla
TSLA
|
$719K |
| 5 |
VICI Properties
VICI
|
$715K |
Sector Composition
| 1 | Healthcare | 22.36% |
| 2 | Technology | 15.51% |
| 3 | Financials | 14.54% |
| 4 | Industrials | 9.65% |
| 5 | Energy | 8.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Kimbell Royalty Partners
KRP
$1.25B
| $200K | 0.13% |
13,267
-70
| -0.5% | -$1.05K |
|
302
NiSource
NI
$18.9B
| $199K | 0.13% |
7,491
+177
| +2% | +$4.7K |
|
303
Devon Energy
DVN
$21.9B
| $198K | 0.13% |
4,371
+206
| +5% | +$9.33K |
|
304
Eversource Energy
ES
$23.3B
| $195K | 0.12% |
3,166
+359
| +13% | +$22.2K |
|
305
Copel
ELP
$6.67B
| $192K | 0.12% |
22,627
-8,518
| -27% | -$72.2K |
|
306
Medical Properties Trust
MPW
$2.75B
| $187K | 0.12% |
38,180
+15,614
| +69% | +$76.7K |
|
307
CEMIG Preferred Shares
CIG
$5.78B
| $183K | 0.12% |
102,540
+2,480
| +2% | +$4.43K |
|
|
DRD
308
DRDGold
DRD
$1.85B
| $181K | 0.12% |
22,781
+4,613
| +25% | +$36.7K |
|
309
ICL Group
ICL
$7.89B
| $181K | 0.11% |
36,126
+1,770
| +5% | +$8.87K |
|
310
Cheniere Energy
CQP
$26B
| $178K | 0.11% |
3,583
-730
| -17% | -$36.3K |
|
|
VRN
311
DELISTED
Veren
VRN
| $177K | 0.11% |
25,592
-5,053
| -16% | -$35K |
|
312
Vodafone
VOD
$28.5B
| $177K | 0.11% |
20,310
-1,322
| -6% | -$11.5K |
|
313
GeoPark
GPRK
$317M
| $172K | 0.11% |
20,047
+189
| +1% | +$1.62K |
|
314
CVR Partners
UAN
$922M
| $169K | 0.11% |
2,579
+124
| +5% | +$8.12K |
|
315
Liquidia Corp
LQDA
$2.41B
| $153K | 0.1% |
12,700
+134
| +1% | +$1.61K |
|
|
BLUE
316
DELISTED
bluebird bio
BLUE
| $136K | 0.09% |
4,942
+1,001
| +25% | +$27.6K |
|
317
Spyre Therapeutics
SYRE
$1.01B
| $134K | 0.09% |
+6,239
| New | +$134K |
|
|
KRTX
318
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $134K | 0.09% |
423
+9
| +2% | +$2.85K |
|
|
PBT
319
Permian Basin Royalty Trust
PBT
$832M
| $131K | 0.08% |
9,390
+950
| +11% | +$13.3K |
|
|
XIFR
320
XPLR Infrastructure, LP
XIFR
$940M
| $129K | 0.08% |
4,232
+957
| +29% | +$29.1K |
|
|
INBX
321
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $128K | 0.08% |
3,362
-316
| -9% | -$12K |
|
322
RAPT Therapeutics
RAPT
$220M
| $119K | 0.08% |
598
+12
| +2% | +$2.39K |
|
|
IGMS
323
DELISTED
IGM Biosciences
IGMS
| $118K | 0.08% |
14,243
+4,334
| +44% | +$36K |
|
324
ImmunityBio
IBRX
$2.27B
| $114K | 0.07% |
22,747
-11,714
| -34% | -$58.8K |
|
325
4D Molecular Therapeutics
FDMT
$326M
| $113K | 0.07% |
5,574
+1,095
| +24% | +$22.2K |
|